Can viscosupplement injections restore the natural cushioning your arthritic knee has lost? These gel-like substances mimic your knee’s natural synovial fluid by delivering hyaluronic acid directly into the joint space. Unlike corticosteroid injections, which primarily reduce inflammation, viscosupplements replenish the joint’s depleted hyaluronic acid levels.
The injected gel creates a protective layer between bones, absorbs mechanical stress during movement, and may stimulate your body’s production of natural hyaluronic acid. This mechanical approach makes viscosupplement an option for patients who cannot tolerate NSAIDs or those seeking to delay knee replacement surgery. If knee pain, stiffness, or reduced mobility is starting to limit daily activities, consulting a knee specialist in Singapore can help determine whether viscosupplement treatment is an appropriate option.
How Viscosupplements Work in Your Knee Joint
Hyaluronic acid molecules in viscosupplements range in molecular weight from 500,000 to 6 million daltons, which determines their viscosity and elasticity properties. Once injected, these long-chain molecules integrate with the remaining synovial fluid, increasing its viscoelastic properties within the joint space.
The treatment creates both immediate mechanical benefits and longer-term biological effects. The mechanical cushioning, a process where the injected gel forms a protective layer on the cartilage surfaces, reduces bone-on-bone contact during weight-bearing activities. This means that when you walk or climb stairs, the gel absorbs the stress that would otherwise be placed directly on the bones, reducing pain and potential damage. The gel’s elasticity also helps absorb shock during impact. Biologically, hyaluronic acid molecules bind to CD44 receptors on chondrocytes (cartilage cells), potentially reducing inflammatory markers like IL-1β and TNF-α while stimulating proteoglycan synthesis.
The knee joint metabolises injected hyaluronic acid within 24-48 hours, but the clinical benefits often persist for 6-12 months. This extended effect suggests that viscosupplements trigger a cascade of reactions that persists after the injected material clears the joint. Research suggests that the treatment may reduce synovial inflammation, decrease nerve sensitivity, and promote the production of endogenous hyaluronic acid, offering hope for long-term relief.
Types of Viscosupplements Available
Standard Molecular Weight Formulations
Hyaluronic acid viscosupplements with molecular weights ranging from 500,000 to 750,000 daltons are available. These formulations typically require 5 weekly injections, each delivering 2mL of a solution containing 10mg/mL hyaluronic acid. The lower molecular weight allows easier diffusion through synovial tissue but requires multiple injections to achieve therapeutic concentrations.
High Molecular Weight Options
Cross-linked hyaluronic acid molecules with a molecular weight of approximately 6 million daltons are available and typically require three weekly injections. The cross-linking process creates a more viscous gel that remains in the joint space for an extended period. Single-injection formulations delivering 6mL of highly concentrated, cross-linked hyaluronic acid are also available, completing the entire treatment course in a single visit.
Intermediate Formulations
Viscosupplements with molecular weights between 2.4 and 2.8 million daltons are available. Some require three injections while others can be administered as a single 4mL injection. These products strike a balance between the benefits of higher molecular weight and the ease of injection.
The source material varies between products. Some derive hyaluronic acid from rooster combs (avian source), while others use bacterial fermentation. Bacterial-derived products eliminate the rare risk of allergic reactions to avian proteins, making them suitable for patients with egg allergies.
The Treatment Process
Initial Assessment
An orthopaedic surgeon evaluates knee X-rays to confirm osteoarthritis severity using the Kellgren-Lawrence grading scale. Grade 2-3 osteoarthritis (mild to moderate joint-space narrowing with osteophyte formation) may respond to viscosupplement therapy. The assessment includes checking for a knee effusion, as excess fluid must be aspirated before injection to ensure proper distribution of the viscosupplement.
Range-of-motion testing establishes a baseline of flexibility. The surgeon also evaluates ligament stability, as significant instability may reduce treatment effectiveness.
Injection Procedure
The injection, which takes 5-10 minutes in an outpatient setting, is a safe and routine procedure. The surgeon uses either a superolateral or anteromedial approach, inserting a 21-gauge needle into the joint space while the patient is seated with the knee flexed at 90 degrees. Image guidance using ultrasound ensures accurate needle placement, particularly important in knees with severe joint space narrowing.
After confirming intra-articular placement by aspirating a small amount of synovial fluid, the surgeon slowly injects the viscosupplement over 20-30 seconds. The gel spreads throughout the joint cavity through passive knee flexion and extension immediately after injection. Patients typically experience minimal discomfort, describing a sensation of fullness in the knee.
Post-Injection Protocol
Patients are advised to avoid strenuous activities for 48 hours after each injection to allow the viscosupplement to evenly distribute throughout the affected area. Light walking encourages circulation without disrupting gel integration. Ice may be applied for 10-15 minutes if mild swelling occurs at the injection site.
Normal daily activities can resume after the initial rest period, but high-impact sports and prolonged standing should be avoided for at least 1 week. Physical therapy exercises focusing on quadriceps strengthening and range of motion can begin 72 hours after the injection. A healthcare professional can provide guidance on the appropriate timing and intensity of exercise.
Expected Results and Timeline
Week 1-2: Initial Response
During the first two weeks, the injected hyaluronic acid begins to integrate with the existing synovial fluid. Some patients experience reduced knee stiffness, particularly in the morning. The viscosupplement starts to form a protective layer on cartilage surfaces, although significant pain relief has not yet been achieved.
Week 3-8: Primary Improvement Phase
Benefit typically occurs several weeks after completing the injection series. Pain reduction becomes noticeable during weight-bearing activities, such as stair climbing or rising from a chair. Walking distance often increases from baseline measurements.
Functional improvements include easier performance of activities requiring knee flexion, such as squatting or kneeling. Clinical assessment scores frequently improve during this period.
Month 3-12: Sustained Benefits
Clinical benefits persist for 6-12 months in responders, with a gradual decline thereafter. Regular monitoring using pain assessment tools helps track the duration of treatment. When pain levels return toward the pre-treatment baseline, a repeat injection series can be considered.
Patients who maintain a healthy body weight and participate in low-impact exercises often experience longer-lasting benefits. Combining viscosupplement treatment with structured physical therapy programs may extend symptom relief beyond the typical duration.
Candidates for Viscosupplement Treatment
Viscosupplements work in specific patient populations with particular characteristics of osteoarthritis. Patients with moderate osteoarthritis show response rates. The treatment may benefit individuals with mechanical symptoms, such as catching or grinding sensations during knee movement.
Active individuals who cannot tolerate oral NSAIDs due to gastrointestinal issues or cardiovascular concerns represent candidates. Viscosupplements offer a systemic medication-free option for managing knee pain while maintaining activity levels. Patients with diabetes may benefit from avoiding corticosteroid injections that can elevate blood glucose levels.
The treatment is suitable for patients who wish to postpone total knee replacement surgery. Younger patients often opt for viscosupplements to maintain joint function, delaying prosthetic implantation until later in life. Those with medical conditions that make them high-risk surgical candidates may also benefit from this non-surgical intervention.
Contraindications include active knee infection, skin disease at the injection site, or known allergy to hyaluronic acid products. Patients with inflammatory arthritis, like rheumatoid arthritis, typically show poor response to viscosupplement treatment. Severe osteoarthritis with complete joint space loss rarely improves with hyaluronic acid injections.
Combining Viscosupplements with Other Treatments
Physical Therapy Integration
Structured physical therapy beginning 72 hours post-injection may help optimise viscosupplement outcomes. Isometric quadriceps exercises can strengthen the primary knee stabiliser muscle. Hamstring stretches may improve posterior flexibility, potentially reducing joint compression during walking.
Aquatic therapy utilises buoyancy to reduce joint loading while maintaining a full range of motion. Water resistance provides gentle strengthening without impact stress. Pool walking complements viscosupplement’s mechanical cushioning effect.
Adjunct Medications
Oral glucosamine sulfate may enhance the effectiveness of viscosupplements through complementary mechanisms. While viscosupplements provide mechanical cushioning, glucosamine potentially supports proteoglycan synthesis in remaining cartilage. Topical NSAIDs like diclofenac gel may help manage residual inflammation without systemic effects. The appropriate dosage and frequency for these medications should be determined by a healthcare professional.
Lifestyle Modifications
Weight reduction, when combined with the cushioning effect of a viscosupplement, may reduce mechanical stress on arthritic cartilage. Low-impact activities, such as cycling or swimming, help maintain cardiovascular fitness without compromising the benefits of treatment.
Proper footwear with shock-absorbing soles and lateral wedge insoles for varus deformity reduces medial compartment loading. Custom orthotics addressing biomechanical abnormalities complement viscosupplement treatment by improving joint alignment during ambulation.
Potential Side Effects and Management
Common Reactions
Injection site discomfort can occur, presenting as mild pain or swelling lasting 24-48 hours. Applying ice and taking paracetamol may help manage discomfort. A healthcare professional can provide guidance on appropriate dosage and frequency.
Knee effusion occasionally develops 12-24 hours after injection, particularly with high-molecular-weight formulations. The effusion typically contains clear, sterile fluid and resolves spontaneously within 72 hours. Knee aspiration is necessary only if the effusion persists beyond 1 week or causes significant discomfort.
Rare Complications
Pseudoseptic reactions can occur, presenting with knee warmth, effusion, and pain mimicking infection but with sterile joint fluid cultures. Treatment involves joint aspiration, NSAIDs, and activity modification. Symptoms typically resolve within 3-7 days without antibiotics.
True septic arthritis remains extremely rare when proper sterile technique is maintained. Signs include fever above 38°C, severe joint pain, and elevated inflammatory markers (CRP > 100 mg/L, ESR > 50mm/h). Immediate joint aspiration for cell count and culture guides antibiotic therapy.
Managing Expectations
Some patients experience a temporary increase in knee discomfort 24-48 hours after the injection, followed by improvement. This “flare” reaction results from the joint accommodating the additional fluid volume.
Commonly Asked Questions
How long do viscosupplement injections last?
Clinical benefits typically persist 6-12 months after completing the injection series. Duration varies based on the severity of osteoarthritis, activity level, and body weight. Patients who maintain regular low-impact exercise and a healthy body weight often experience benefits that last for up to 12 months. Repeat injection series can be administered when symptoms return.
Can viscosupplements be used in joints other than the knees?
While FDA approval covers knee osteoarthritis, orthopaedic surgeons sometimes use viscosupplements off-label for hip, shoulder, and ankle arthritis as well. Hip injections require image guidance due to the deep joint location. Smaller joints, such as ankles, require adjusted dosing, typically with 1-2mL volumes. Evidence for non-knee joints remains less robust than that for knee treatment.
What’s the difference between viscosupplements and PRP injections?
Viscosupplements provide immediate mechanical cushioning through a hyaluronic acid gel, while platelet-rich plasma (PRP) delivers growth factors that may stimulate tissue healing. Viscosupplements provide predictable symptom relief that lasts 6-12 months. PRP results vary more widely, with some patients experiencing longer-lasting improvement. The cost differs significantly, with viscosupplements generally covered, while PRP remains a self-pay option.
How soon can I exercise after viscosupplement injections?
Light walking can resume immediately; however, avoid strenuous activities for 48 hours after the injection. Low-impact exercises, such as stationary cycling or swimming, can be started after 72 hours. High-impact activities, such as running or jumping, should be avoided for 1-2 weeks to allow optimal viscosupplement distribution. Progressive return to sports follows individual response to treatment.
Will viscosupplements help bone-on-bone arthritis?
Severe osteoarthritis with complete cartilage loss responds poorly to viscosupplement treatment. The injection requires some remaining joint space for the gel to occupy and provide cushioning. X-rays showing bone-on-bone contact indicate advanced disease that may be suited for total knee replacement. However, some patients with severe arthritis in one compartment but preserved space in others may still benefit from treatment.
Conclusion
Viscosupplement injections provide mechanical cushioning for knee osteoarthritis by supplementing with hyaluronic acid, offering 6-12 months of symptom relief. Success requires proper patient selection, specifically those with grade 2-3 osteoarthritis, and integration with physical therapy for optimal outcomes. The treatment serves as a bridge option for those seeking to delay surgical intervention while maintaining activity levels.
If you’re experiencing knee pain, stiffness, or mechanical symptoms related to osteoarthritis, an orthopaedic specialist in Singapore can assess whether viscosupplement treatment is suitable for your condition.
